HIV und schwangerschaft: Risiken der übertragung und therapeutische Möglichkeiten

Gynakologisch-geburtshilfliche Rundschau

Volumn 36, Issue 4, 1996, Pages 188-193

  Ibe, M ^a   Knolle, P ^a   Beck, T ^b   Meyer zam Buschenfelde K H ^a   Gerkena, G ^a  

^a Mcdizinische Klinik und Poliklinik   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

AIDS; Antiretroviral therapy; HIV; Vertical transmission

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR;

ANTI-HIV AGENTS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; ZIDOVUDINE;

EID: 0030321237     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000272661     Document Type: Article

References (36)

1. Chin J: Global cstimatcsof HIV infections and AIDS cases 1991. AIDS 1991:5(suppl 2):57-61.
2. Hamouda O. Koch MA. Schwartländcr B: AIDS/HIV 1994: Bericht zur epidemiologischen Situation in der BRD zum 31.,12.,1994. AIDS Zentrum BGA 1994. AZ-Hefte 1994. 20.
3. 120. Bericht des AIDS-Zentrums im Robert-Koch-Institut über aktuelle epidemiologische Daten: Quartalsbericht 1 V/95.
4. Landesmann SH, Minkhoff HL, Holman S. McCalla S, Sihin O: Serosurvey of HIV infection in parturients. JAMA 1987:258:2701-2703.
5. Payati SP. Aduana S, Tsui PT. Gokhalc R. Telischi M, Jacobs NM. Pildes RS: Asymptomatic maternal HIV virus infection: Risk profile and pregnancy outcome. J Matern Fetal Med 1993;2:79-84.
6. Biedermann K, Rudin C, Irion O. Spoletini G. Laupcr U. Kind C: Schwangerschaften bei HIV-infizierten Frauen in der Schweiz. Geburtshilfe Frauenheilkd 1995:55:447-455.
7. European Collaborative Study: Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-1012.
8. Feng Y, Broder CC, Kennedy PE, Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science 1996:272:872-876.
9. Lairmorc MD. Culhbert PS. Utley LL. Morgan CJ, Dezzutti CS, Anderson CL, Sedmak DD: Cellular localization of CD4 in the human placenta. J Immunol 1993;151:1673-1681.
10. Douglas GC. King BF: Maternal-fetal transmission of human immunodeficiency virus: A review of possible routes and cellular mechanisms of infection. Clin Infect Dis 1992:15: 678-691.
11. Hcnin Y. Mandelbrot L. Montagnicr L: Virus excretion in cervicovaginal secretion of pregnant and nonpregnant HIV-infected women. J Acquir Immune Defic Syndr 1993:6:2-6.
12. St Louis ME, Kamenga M. Brown C, Nelson AM, Batter V, Bchets F. Kabagabo U, Ryder RW. Quinn TC. Heyward WL: Risk for perinatal HIV-I transmission according to maternal, immunologic virologic and placental factors. JAMA 1993;269:2853-2859.
13. Dickovcr RE, Garratty EM. Herman SA, Sim MS, Plaeger S. Boyer PJ. Keller M, Dcveikis A. Stiehm ER. Bryson YJ: Identification of levels of maternal HIV-1-RNA associated with risk of perinatal transmission. JAMA 1996:275:599-605.
14. Landesmann SH, Kalish LA. Burns DN. Mink-hoff H, Fox HE. Zorrilla C. Garcia P. Fowler MG, Mofenson L. Tuomala R: Obstetrical factors and the transmission ofHIV-l from mother to child. N Engl J Med 1996:334:1617-1623.
15. Cirau-Vigneron N. Lefcvre V. Lepage E. Ravi-na JH: Obstetrical risk factors in HIV-1 vertical transmisison. Pediatr AIDS 1993:4:304.
16. Minkhof T H. Bums DN. Landesmann S, You-chah J. Goedcrt JJ, Nugent RP. Muenz LR. Willoughby AD: The relationship of the duration of ruptured membranes to vertical transmission of human immunodeficieny virus. Am J Obstet Gynecol 1995:173:585-589.
17. Alger LS. Parley JJ. Robinson BA, Hines BE, Berchin JM. Johnson JP: Interactions of HIV infection and pregnancy. Obstet Gynecol 1993: 82:787-796.
18. Temmerman M. Chomba EN. Ndinya-Achola J. Plummer FA, Coppens M. Piot P: Maternal HIV-1 infection and pregnancy outcome. Obstet Gynecol 1994;83:495-501.
19. Fang G, Burger H. Grimson R. Tropper P, Nachman S. Mayers D. Weislow O. Moore R. Reyelt C, Hutcheon N: Maternal plasma human immunodeficiency virus type I RNA level: A determinant and projected threshold for mothcr-to-child transmission. Proc Nall Acad Sci USA 1995:92:12100-12104.
20. Sperling RS. Stratton P. O’Sullivan JM. Boyer P. Watts DH, Lambert JS. Ilammill H. Livingston E. Fox HE: A survey of zidovudine use in pregnant women with HIV infection. N Engl J Med 1992;326:857-861.
21. Ferrazin A. De Maria A. Gotta C. Mazzarello G. Canessa A. Ciravcegna B. Mclica F. Terra-gna A: Zidovudine therapy of HIV-1 infection during pregnancv. J Acquir Immune Dcfic Syndr 1993:6:376-379.
22. Watts DH, Brown ZA. Tartaglionc T. Burchett SK. Ophcim K, Coombs R. Corey L: Pharma-kokinetic disposition of zidovudine during pregnancy. J Infect Dis 1991:163:226-232.
23. Report: Zidovudine for the prevention of HIV transmission from mother to infant. MMWR 1994:43:285-287.
24. Mathcson PB. Abrams EJ. Thomas PA. Her-nan MA. Tliea DM. LAmbert G. Krasinski K. Bamji M, Rogers MF. Hcagarty M: Efficacy of antenatal zidovudine in reducing perinatal transmission of HIV type I. The New York City Perinatal HIV Transmission Collaborative Study Group. J Infect Dis 1995; 172:353-358.
25. Frenkel LM. Wagner LE. Demetcr LM. Dew-hurst S. Coombs RW. Murante BL, Reichman RC: Effects of zidovudine use during pregnancy on resistance and vertical transmission of human immunodeficiency virus type I. Clin Infect Dis 1995:20:1321-1326.
26. Gabiano C, Tovo PA. de Martino M, et al: Mother to child transmission of HIV: Risk of infection and correlates of transmission. Pediatrics 1992;90:362-374.
27. Villari P. Spino C. Chalmers TC, Laun J, Sacks S: Caesarean section to reduce perinatal transmission of human immunodeficiency virus. Online J Curr Clin Trials 1993:7:74.
28. European Collaborative Study: Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994:343:1464-1467.
29. Ehrnst A. Lindgren S. Dictzor M. Johansson B. Sonneborg A, Czajkowki J. Sundin G, Bohlin A-B: HIV in pregnant women and their offspring: Evidence for late transmission. Lancet 1991;338:203-207.
30. Goedcrt J. Dulicgc AM. Amos CL Felton S. Biggar RJ: High risk of HIV-1 infection for first-born twins. Lancet 1991;338:1471-1475.
31. Blanche S. Rouzioux C, Giuhard Moscato M L. Vcbcr F. Mayaux MJ. Jacomet C: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-1648.
32. European Collaborative Study: Natural history of vertically acquired HIV-1 infection. Pediatrics 1994:94:815-819.
33. Henderson DK: Risk occupational transmission of HIV-1 associated with clinical exposures: A prospective evaluation. Ann Intern Med 1990:113:740-746.
34. Tokars JI, Marcus R: Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann Intern Med 1993:118: 913-919.
35. CDC: Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood-France. United Kingdom and United States, January 1988 to August 1994. MMWR 1995:44:929-933.
36. CDC: Update: Provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV. MMWR 1996:45:468-480.